Real-World Impact of Deep Targeted Sequencing on Erythrocytosis and Thrombocytosis Diagnosis: A Reference Centre Experience
Alberto Blanco Sánchez(Hospital Universitario 12 De Octubre), Gonzalo Carreño‐Tarragona, Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Rodrigo Gil-Manso(Spanish National Cancer Research Centre), Nieves López‐Muñoz, Ricardo Sánchez(Research Institute Hospital 12 de Octubre), Rosa Ayala(Hospital Universitario 12 De Octubre), Rafael Colmenares(Hospital Universitario 12 De Octubre), Inmaculada Rapado(Wellcome Sanger Institute), Reyes Mas(Universidad Complutense de Madrid), Rodrigo de Nicolás(Hospital Universitario 12 De Octubre)
Cited by 1
Related Papers
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523